Resumen
In recent years, targeted therapy has significantly improved the lives of patients suffering from spine metastasis. However, traditional scoring systems used to predict treatment outcomes may not reflect these advancements. This study aims to explore the latest literature on medical therapy options for metastatic spinal tumors, particularly focusing on targeted therapy compared to other treatments. Through a systematic review and data analysis, this research highlights the effectiveness of targeted therapy, especially in lung and breast cancers, in prolonging the median overall survival. By considering the recent advances in medical oncology, these findings emphasize the importance of incorporating personalized treatment approaches into the management of metastatic spine tumors. This study provides valuable insights for clinicians and researchers in optimizing treatment strategies for patients with spinal metastases.